StonvexLoading…
StonvexStonvexStonvexCore line items from YCBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $19.19M | $19.92M | $25.05M | $37.12M |
Operating Income | $-2.16M | $-3.32M | $-22.49M | $-78.27M |
Net Income | $-2.04M | $-3.70M | $-22.94M | $-70.08M |
EPS (Diluted) | $-1.09 | $-14.29 | $-13.32 | $-55.80 |
Total Assets | $10.42M | $10.58M | $16.20M | $40.79M |
Total Liabilities | $3.19M | $8.62M | $7.16M | $9.37M |
Cash & Equivalents | $2.26M | $2.45M | $1.80M | $6.72M |
Free Cash Flow OCF − CapEx | $-1.64M | $-542.81K | $-4.60M | $-15.66M |
Shares Outstanding | 8.92M | 492.38K | 2.96M | 1.35M |